EUVIMEDEUVIMED entdecken
Crossref

Individual-level metabolic connectivity from dynamic [18F]FDG PET reveals glioma-induced impairments in brain architecture and offers novel insights beyond the SUVR clinical standard

Giulia Vallini iD, Erica Silvestri iD, Tommaso Volpi iD, John J Lee iD, Andrei G Vlassenko, Manu S Goyal iD, Diego Cecchin iD, Maurizio Corbetta iD, Alessandra Bertoldo iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-024-06956-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Giulia Vallini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Information Engineering, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Glioma, Fluorodeoxyglucose F18, Brain Neoplasms, Positron-Emission Tomography. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NIH/NIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study evaluates the potential of within-individual Metabolic Connectivity (wi-MC), from dynamic [18F]FDG PET data, based on the Euclidean Similarity method. This approach leverages the biological information of the tracer's full temporal dynamics, enabling the direct extraction of individual metabolic connectomes. Specifically, the proposed framework, applied to glioma pathology, seeks to assess sensitivity to metabolic dysfunctions in the whole brain, while simultaneously providing further insights into the pathophysiological mechanisms regulating glioma progression. METHODS: We designed an index (Distance from Healthy Group, DfHG) based on the alteration of wi-MC in each patient (n = 44) compared to a healthy reference (from 57 healthy controls), to individually quantify metabolic connectivity abnormalities, resulting in an Impairment Map highlighting significantly compromised areas. We then assessed whether our measure of metabolic network alteration is associated with well-established markers of disease severity (tumor grade and volume, with and without edema). Subsequently, we investigated disruptions in wi-MC homotopic connectivity, assessing both affected and seemingly healthy tissue to deepen the pathology's impact on neural communication. Finally, we compared network impairments with local metabolic alterations determined from SUVR, a validated diagnostic tool in clinical practice. RESULTS: Our framework revealed how gliomas cause extensive alterations in the topography of brain networks, even in structurally unaffected regions outside the lesion area, with a significant reduction in connectivity between contralateral homologous regions. High-grade gliomas have a stronger impact on brain networks, and edema plays a mediating role in global metabolic alterations. As compared to the conventional SUVR-based analysis, our approach offers a more holistic view of the disease burden in individual patients, providing interesting additional insights into glioma-related alterations. CONCLUSION: Considering our results, individual PET connectivity estimates could hold significant clinical value, potentially allowing the identification of new prognostic factors and personalized treatment in gliomas or other focal pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaFluorodeoxyglucose F18Brain NeoplasmsPositron-Emission TomographyBrainHumansMaleFemaleMiddle AgedAdultAgedRadiopharmaceuticalsReference Standards

Stichwörter der Autor:innen

Brain network alterationsCancer neuroscienceGliomaIndividual-level metabolic connectivitySUVR[18F]FDG dynamic PET

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Information Engineering, University of Padova, Padova, Italy.
  • Padova Neuroscience Center, University of Padova, Padova, Italy.
  • Department of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
  • Neuroimaging Laboratories, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA.
  • Department of Medicine, Unit of Nuclear Medicine, University of Padova, Padova, Italy.
  • Department of Neuroscience, University of Padova, Padova, Italy.

ORCID-Profile: Giulia Vallini, Erica Silvestri, Tommaso Volpi, John J Lee, Manu S Goyal, Diego Cecchin, Maurizio Corbetta, Alessandra Bertoldo

Förderung

  • NIH/NIA

Zitieren

APA

Vallini, G., Silvestri, E., Volpi, T., Lee, J. J., Vlassenko, A. G., Goyal, M. S., Cecchin, D., Corbetta, M., & Bertoldo, A. (2025). Individual-level metabolic connectivity from dynamic [18F]FDG PET reveals glioma-induced impairments in brain architecture and offers novel insights beyond the SUVR clinical standard. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06956-8

Vancouver

Vallini G, Silvestri E, Volpi T, Lee JJ, Vlassenko AG, Goyal MS, et al. Individual-level metabolic connectivity from dynamic [18F]FDG PET reveals glioma-induced impairments in brain architecture and offers novel insights beyond the SUVR clinical standard. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-06956-8

BibTeX
@article{Vallini2025,
  author = {Vallini, Giulia and Silvestri, Erica and Volpi, Tommaso and Lee, John J and Vlassenko, Andrei G and Goyal, Manu S and Cecchin, Diego and Corbetta, Maurizio and Bertoldo, Alessandra},
  title = {Individual-level metabolic connectivity from dynamic [18F]FDG PET reveals glioma-induced impairments in brain architecture and offers novel insights beyond the SUVR clinical standard},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-024-06956-8}
}
Kostenlos starten →